Features Archives - Page 39 of 52 - MedShadow Foundation | Independent Health & Wellness Journalism

Is Naloxone Harmful to a Person Not Overdosing?

Is Naloxone Harmful to a Person Not Overdosing?

Kids' COVID Vaccine: Concerns About Myocarditis

Kids’ COVID Vaccine: Concerns About Myocarditis

Warning: Drug Ads May Cause Confusion

Healthy Skeptic 2

Warning: Drug Ads May Cause Confusion

Suzanne B. Robotti

Calcium Supplements: Pros, Cons & Expert Tips

Calcium Supplements: Pros, Cons & Expert Tips

Health, Not Health Care is the Goal

Healthy Skeptic new

Health, Not Health Care is the Goal

Suzanne B. Robotti

HCQ Increases Chance of Death in COVID-19 Patients & More

HCQ Increases Chance of Death in COVID-19 Patients & More

Featured Articles New Stories

Food as Medicine: Osteoarthritis

Geri Anne Fennessey

FDA Requiring Long-Term Research of OxyContin Use

FDA Requiring Long-Term Research of OxyContin Use

Suzanne B. Robotti

How to Track Your Disease Triggers, Symptoms, and Side Effects

How to Track Your Disease Triggers, Symptoms, and Side Effects

FDA

Quick Hits: Opioid Meds, FDA Warnings & More

Finding a Med or Therapy for ADHD

Finding a Med or Therapy for ADHD

Suzanne B. Robotti

'Pink Viagra'? Why We Shouldn't Rush to 'Fix' Women's Bodies

‘Pink Viagra’? Why We Shouldn’t Rush to ‘Fix’ Women’s Bodies

Medshadow Staff

Issues Related to Healthcare Wellness Articles

Exercise Boosts Tumor-fighting Ability of Chemotherapy

Quick Hits: Guidelines For Hypertension Treatment & More

Quick Hits: Guidelines For Hypertension Treatment & More

Dealing With Side Effects of Arthritis Medications

Dealing With Side Effects of Arthritis Medications

Prescription joke: Take 11 and Call Me in the Morning

The Many Ways To Manage Migraine Treatment

Featured Articles New Stories

The Many Ways To Manage Migraine Treatment

Study: Hair Relaxers Linked To Breast Cancer Risk

Featured Articles

Study: Hair Relaxers Linked To Breast Cancer Risk

Kimberly Bertrand

For Back Pain, Try Non-Drug Measures First

FDA Approves Radicava, First New ALS Drug In More Than 2 Decades

FDA Approves Radicava, First New ALS Drug In More Than 2 Decades

Load More

x